The Bayesian Conspiracy 36 – The Other Kind of Drugs
13 snips
Jun 7, 2017 A wide-ranging conversation about drugs, from how prevention programs like DARE can backfire to the gradual pathways from prescriptions to heroin. They contrast psychedelics, MDMA, alcohol and stimulants and discuss neurotoxicity and long-term personality shifts. Harm-reduction models like Portugal and wet houses get attention, along with safe-setting tips, market risks like fentanyl, and the ethics of legalization and regulation.
AI Snips
Chapters
Transcript
Episode notes
Psychedelics Can Reveal Rather Than Cause Illness
- Psychedelic use doesn't clearly raise long-term psychiatric illness rates but can precipitate underlying conditions.
- Participants reported lasting personality shifts like increased openness after high-dose psilocybin studies.
Bring A Sober Trusted Sitter
- Use a sober trusted sitter and control setting when trying psychedelics to reduce bad trips.
- Eneasz recommends someone you love who will stay sober and support you through the experience.
Decriminalize To Improve Harm Reduction
- Decriminalization and harm reduction (Portugal, wet houses) reduce harms by removing stigma and enabling help-seeking.
- Eneasz cites Portugal and wet houses as examples where nonpunitive approaches improve outcomes.